These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1670597)

  • 1. Comparison of vecuronium- and atracurium-induced neuromuscular blockade in postpartum and nonpregnant patients.
    Khuenl-Brady KS; Koller J; Mair P; Pühringer F; Mitterschiffthaler G
    Anesth Analg; 1991 Jan; 72(1):110-3. PubMed ID: 1670597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of vecuronium and atracurium in an in vitro nerve-muscle preparation.
    Van der Spek AF; Zupan JT; Pollard BJ; Schork MA
    Anesth Analg; 1988 Mar; 67(3):240-6. PubMed ID: 2894184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betamethasone-induced resistance to neuromuscular blockade: a comparison of atracurium and vecuronium in vitro.
    Robinson BJ; Lee E; Rees D; Purdie GL; Galletly DC
    Anesth Analg; 1992 May; 74(5):762-5. PubMed ID: 1348914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atracurium and vecuronium on the latency and the duration of the negative deflection of the evoked compound action potential of the adductor pollicis.
    Pugh ND; Harper NJ; Healy TE; Petts HV
    Br J Anaesth; 1987 Feb; 59(2):195-9. PubMed ID: 2881565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous recovery of residual neuromuscular blockade after atracurium or vecuronium during isoflurane anaesthesia.
    Erkola O; Karhunen U; Sandelin-Hellqvist E
    Acta Anaesthesiol Scand; 1989 May; 33(4):290-4. PubMed ID: 2566251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the power spectrum of the evoked compound action potential of the adductor pollicis with the onset of neuromuscular blockade.
    Harper NJ; Pugh ND; Healy TE; Petts HV
    Br J Anaesth; 1987 Feb; 59(2):200-5. PubMed ID: 2881566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between vecuronium and atracurium in myasthenia gravis.
    Chan KH; Yang MW; Huang MH; Hseu SS; Chang CC; Lee TY; Lin CY
    Acta Anaesthesiol Scand; 1993 Oct; 37(7):679-82. PubMed ID: 7902637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the neuromuscular and cardiovascular effects of vecuronium, atracurium and mivacurium in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):233-7. PubMed ID: 9690609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J
    Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.
    Bevan DR; Smith CE; Donati F
    Anesthesiology; 1988 Aug; 69(2):272-6. PubMed ID: 2900612
    [No Abstract]   [Full Text] [Related]  

  • 15. Potency and maintenance requirement of atracurium and vecuronium given alone or together.
    Rautoma P; Erkola O; Meretoja OA
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):220-3. PubMed ID: 7793191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
    Gramstad L
    Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cyclosporin and its solvent, Cremophor, with atracurium and vecuronium. Studies in the cat.
    Gramstad L; Gjerløw JA; Hysing ES; Rugstad HE
    Br J Anaesth; 1986 Oct; 58(10):1149-55. PubMed ID: 2876721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vecuronium and atracurium in patients with end-stage renal failure. A comparative study.
    Lepage JY; Malinge M; Cozian A; Pinaud M; Blanloeil Y; Souron R
    Br J Anaesth; 1987 Aug; 59(8):1004-10. PubMed ID: 2888474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vecuronium and prolonged neuromuscular blockade in postpartum patients.
    Camp CE; Tessem J; Adenwala J; Joyce TH
    Anesthesiology; 1987 Dec; 67(6):1006-8. PubMed ID: 2891326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.